CASP3 and chronic obstructive pulmonary disease: Administered via pulmonary delivery, Que-lipo regulated the expression of key apoptosis-associated proteins such as Bcl-2 and caspase-3/7, leading to significant inhibition of apoptotic activity in COPD.